Cost-Effectiveness Analysis of Tocilizumab Verse Infliximab for the Patients With Rheumatoid Arthritis in Kazakhstan
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.2607
https://www.valueinhealthjournal.com/article/S1098-3015(14)04556-2/fulltext
Title :
Cost-Effectiveness Analysis of Tocilizumab Verse Infliximab for the Patients With Rheumatoid Arthritis in Kazakhstan
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)04556-2&doi=10.1016/j.jval.2014.08.2607
First page :
A379
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
311